Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-05-30

FDA Approved: TRI-LINYAH — Original Application (Northstar Rx LLC)

View source ↗

Summary

FDA approved TRI-LINYAH, a generic combined oral contraceptive containing norgestimate and ethinyl estradiol, under an original application from Northstar Rx LL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRI-LINYAH (NORGESTIMATE AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for TRI-LINYAH (NORGESTIMATE AND ETHINYL ESTRADIOL)